TwitterLinkedInFacebook Instagram
United StatesLanguage Flag

Press Release

OraSure to Open NASDAQ Stock Market in Honor of National HIV Testing Day; Company Will Also Donate OraQuick Rapid HIV-1 Antibody Tests

June 22, 2004 at 9:00 AM EDT

BETHLEHEM, Pa.--(BUSINESS WIRE)--June 22, 2004--OraSure Technologies, Inc. (NASDAQ NM:OSUR), the market leader in oral fluid diagnostics, announced today that its OraQuick(R) Rapid HIV-1 Antibody Test will be donated to numerous locations across the United States to conduct free HIV testing in observance of National HIV Testing Day on June 27, 2004. Additionally, in further recognition of this annual observance, OraSure Technologies will preside over the opening of The NASDAQ Stock Market on Friday, June 25.

June 27, 2004, will mark the tenth annual National HIV Testing Day, an annual campaign sponsored by the National Association of People with AIDS to encourage at-risk individuals to receive voluntary HIV counseling and testing. According to the Centers for Disease Control and Prevention, an estimated 280,000 people in the United States currently have the HIV virus but may be unaware that they are infected.

"We are honored to be working with so many dedicated state and local organizations for National HIV Testing Day to help stem the spread of the HIV virus, and proud to be able to open The NASDAQ Stock Market on such an important date," said Mike Gausling, President and Chief Executive Officer of OraSure Technologies. "In order to help stop the spread of HIV/AIDS and provide treatment to those in need, it is critical that individuals who may be infected learn their HIV status. We believe that our OraQuick(R) test will help increase the number of people who get tested and learn their HIV results, and we will continue to work in partnership with local, state and national agencies to help make this happen."

OraSure Technologies National HIV Testing Day 2004 Partner Sites

OraSure has partnered with the following specific sites in observance of National HIV Testing Day, which will be offering free OraQuick(R) Rapid HIV-1 Antibody Tests:

    --  Ebony House, Inc., AZ
    --  L.A. Gay and Lesbian Center, CA
    --  San Diego County, Health and Human Services Agency, Office of
        AIDS Coordination, CA
    --  Whitman-Walker Clinic, Washington, D.C.
    --  Family and Medical Counseling Services, Washington, D.C.
    --  South Beach AIDS Project, FL
    --  Our Common Welfare, Inc., GA
    --  Chicago Department of Public Health, IL
    --  Brookdale University Hospital, Treatment for Life Center, NY
    --  Metrolina AIDS Project, NC
    --  AIDS Resource Center, OH
    --  Ohio Department of Health - HIV Prevention Program, OH
    --  Delaware County State Health Center, PA
    --  Lehigh Valley Hospital Center, AIDS Activity Office, PA
    --  Berks AIDS Network, PA
    --  Chattanooga-Hamilton County Southeast Regional Advisory
        Committee on HIV, TN
    --  BEAT AIDS, Inc., TX
    --  Community Clinic San Antonio ,TX
    --  Hope Action Care, TX
    --  Mujeres Unidas San Antonio, TX
    --  San Antonio AIDS Foundation, TX
    --  San Antonio Metropolitan Health District, TX
    --  We Are Alive San Antonio, TX

    NASDAQ Market Open

Mike Gausling, OraSure's President and Chief Executive Officer, and Ron Spair, OraSure's Chief Financial Officer, are scheduled to preside over The NASDAQ Market Open ceremony beginning at 9:20 a.m. Following the event, the Market Open ceremony will be available for viewing online at http://www.nasdaq.com/reference/marketsite_about.stm.

NASDAQ Video Satellite Feed Available on June 25

Please Note: "Live" coverage of The NASDAQ Stock Market opening ceremony on Friday, June 25, from 9:20 a.m. to 9:35 a.m. EDT is available via satellite on Galaxy 4R C/Transponder 21. The downlink frequency is 4120 horizontal; audio: 6.2/6.8. The feed can also be found on Waterfront fiber 1623. For questions, please contact the NASDAQ Traffic Department at (646) 441-5220.

OraSure Interview Footage and B-Roll Available June 25

A satellite uplink with National HIV Testing Day interview footage and b-roll will be available via a satellite on Friday, June 25 at 2:00 - 2:15 PM EDT. Coordinates for the satellite uplink are:


Date:               6-25-04
Time:               2:00 PM - 2:15 PM EDT
Satellite:          KU Band
                    SBS 6, Transponder 2
                    Audio: 6.2, 6.8 full program mix
                    74 degrees West
                    Downlink frequency: 11749.5 mhz vertical polarity

National HIV Testing Day footage will include: statements from NASDAQ Stock Market Opening Ceremony; b-roll of OraQuick(R) HIV Test procedure with oral fluid and fingerstick whole blood; scenes from Whitman-Walker Clinic including HIV counseling; and test manufacturing.

About OraSure Technologies

OraSure Technologies develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well as internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities.

OraSure Technologies is the leading supplier of oral-fluid collection devices and assays to the life insurance industry and public health markets for the detection of antibodies to HIV-1. In addition, the Company supplies oral-fluid testing solutions for drugs of abuse testing. For more information on the Company, please go to www.orasure.com.

Important Information

This press release contains certain forward-looking statements, including with respect to products, regulatory submissions and approvals. Actual results could be significantly different. Factors that could affect results include the ability to market products; impact of competitors, competing products and technology changes; ability to develop, commercialize and market new products; market acceptance of oral fluid testing products and up-converting phosphor technology products; ability to fund research and development and other projects and operations; ability to maintain new or existing product distribution channels (including OraSure's ability to implement a direct sales effort or other alternative distribution for OraQuick(R)); reliance on sole supply sources for critical product components; availability of related products produced by third parties; ability to obtain and timing of obtaining necessary regulatory approvals; ability to comply with applicable regulatory requirements; history of losses and ability to achieve sustained profitability; volatility of our stock price; uncertainty relating to patent protection and potential patent infringement claims; ability to obtain licenses to patents or other technology; ability to enter into international manufacturing agreements; obstacles to international marketing and manufacturing of products; ability to sell products internationally; loss or impairment of sources of capital; ability to meet financial covenants in agreements with financial institutions; ability to retain qualified personnel; exposure to product liability and other types of litigation; changes in international, federal or state laws and regulations; changes in relationships with strategic partners and reliance on strategic partners for the performance of critical activities under collaborative arrangements; changes in accounting practices or interpretation of accounting requirements; customer consolidations and inventory practices; equipment failures and ability to obtain needed raw materials and components; the impact of terrorist attacks and civil unrest; ability to complete consolidation or restructuring activities; ability to identify, complete and realize the full benefits of potential acquisitions; and general political, business and economic conditions. These and other factors are discussed more fully in the Securities and Exchange Commission ("SEC") filings of OraSure Technologies, including its registration statements, its Annual Report on Form 10-K for the year ended December 31, 2003, its Quarterly Reports on Form 10-Q, and its other filings with the SEC. Although forward-looking statements help to provide complete information about future prospects, readers should keep in mind that forward-looking statements may not be reliable. The forward-looking statements are made as of the date of this press release and OraSure Technologies undertakes no duty to update these statements.


    CONTACT: OraSure Technologies, Inc.
             Investor Contact:
             Ronald H. Spair, 610-882-1820
             Investorinfo@orasure.com
             www.orasure.com
             or
             Media Contacts:
             Zer0 to 5ive
             Ron Ticho or Jennifer Moritz
             610-360-0205 or 718-623-0355
             rticho@orasure.com or jmoritz@0to5.com

    SOURCE: OraSure Technologies, Inc.
© OraSure Technologies., 2024